The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee

Clinical trial NCT02464501 · COMPLETED

Trial details

NCT number: NCT02464501
Sponsor: Horizons International Peripheral Group
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Peripheral Arterial Disease Cardiovascular Disease Peripheral Vascular Disease

Start date: 2015-05-20
Primary completion: 2019-09-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.